Legat, FJ; Gruber-Wackernagel, A; Hofer, A; Waltner, K; Wolf, P.
Aprepitant, a NK1-antagonist, administered for 16 weeks reduced itch and supported resolution of skin lesions in a patient with chronic prurigo
J INVEST DERMATOL. 2017; 137(10):S204-S204.-47th Annual Meeting of the European-Society-for-Dermatological-Research (ESDR); SEP 27-30, 2017; Salzburg, AUSTRIA.
Doi: 10.1016/j.jid.2017.07.167
[Poster]
Web of Science
FullText
FullText_MUG